Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-20-032143)

Filing Details

Accession Number:
0001209191-20-032143
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-26 17:55:17
Reporting Period:
2020-05-21
Accepted Time:
2020-05-26 17:55:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571469 Athena Countouriotis C/O Turning Point Therapeutics, Inc.
10628 Science Center Drive, Ste. 200
San Diego CA 92121		 President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-21 4,166 $60.00 26,872 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were purchased in connection with the Issuer's public offering.